BOK Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $839K | Sell |
1,346
-5
| -0.4% | -$3.4K | 0.01% | 460 |
|
|
2026
Q1 | $1.04M | Sell |
1,351
-25
| -2% | -$19.1K | 0.02% | 416 |
|
|
2025
Q4 | $1.06M | Sell |
1,376
-172
| -11% | -$117K | 0.02% | 413 |
|
|
2025
Q3 | $870K | Sell |
1,548
-637
| -29% | -$360K | 0.01% | 466 |
|
|
2025
Q2 | $1.15M | Buy |
2,185
+14
| +0.6% | +$7.81K | 0.02% | 430 |
|
|
2025
Q1 | $1.38M | Sell |
2,171
-1,032
| -32% | -$710K | 0.02% | 397 |
|
|
2024
Q4 | $2.23M | Buy |
3,203
+1,458
| +84% | +$1.22M | 0.04% | 318 |
|
|
2024
Q3 | $1.77M | Sell |
1,745
-220
| -11% | -$245K | 0.03% | 360 |
|
|
2024
Q2 | $2.07M | Buy |
1,965
+120
| +7% | +$116K | 0.04% | 347 |
|
|
2024
Q1 | $1.79M | Sell |
1,845
-30
| -2% | -$28.5K | 0.03% | 384 |
|
|
2023
Q4 | $1.65M | Buy |
1,875
+13
| +0.7% | +$10.7K | 0.03% | 376 |
|
|
2023
Q3 | $1.45M | Sell |
1,862
-2,015
| -52% | -$1.58M | 0.03% | 377 |
|
|
2023
Q2 | $2.79M | Buy |
3,877
+172
| +5% | +$133K | 0.06% | 285 |
|
|
2023
Q1 | $3.04M | Sell |
3,705
-834
| -18% | -$629K | 0.06% | 267 |
|
|
2022
Q4 | $3.27M | Buy |
4,539
+495
| +12% | +$365K | 0.06% | 283 |
|
|
2022
Q3 | $2.79M | Buy |
4,044
+182
| +5% | +$115K | 0.06% | 300 |
|
|
2022
Q2 | $2.28M | Sell |
3,862
-4
| -0.1% | -$2.6K | 0.04% | 336 |
|
|
2022
Q1 | $2.7M | Buy |
3,866
+143
| +4% | +$90.5K | 0.04% | 338 |
|
|
2021
Q4 | $2.35M | Sell |
3,723
-38
| -1% | -$23.4K | 0.04% | 369 |
|
|
2021
Q3 | $2.28M | Buy |
+3,761
| New | +$2.33M | 0.04% | 368 |
|
|
2021
Q1 | $2.59M | Sell |
5,483
-755
| -12% | -$368K | 0.05% | 336 |
|
|
2020
Q4 | $3.01M | Buy |
6,238
+589
| +10% | +$318K | 0.06% | 293 |
|
|
2020
Q3 | $3.16M | Sell |
5,649
-650
| -10% | -$394K | 0.07% | 252 |
|
|
2020
Q2 | $3.93M | Sell |
6,299
-77
| -1% | -$43.7K | 0.09% | 210 |
|
|
2020
Q1 | $3.11M | Buy |
6,376
+2,431
| +62% | +$1M | 0.09% | 223 |
|
|
2019
Q4 | $1.48M | Buy |
3,945
+86
| +2% | +$28.9K | 0.03% | 420 |
|
|
2019
Q3 | $1.07M | Sell |
3,859
-1,338
| -26% | -$396K | 0.03% | 480 |
|
|
2019
Q2 | $1.63M | Sell |
5,197
-27
| -0.5% | -$8.99K | 0.04% | 375 |
|
|
2019
Q1 | $2.15M | Buy |
5,224
+108
| +2% | +$44.5K | 0.05% | 337 |
|
|
2018
Q4 | $1.91M | Buy |
5,116
+1,311
| +34% | +$480K | 0.05% | 326 |
|
|
2018
Q3 | $1.54M | Buy |
3,805
+347
| +10% | +$132K | 0.04% | 420 |
|
|
2018
Q2 | $1.19M | Sell |
3,458
-692
| -17% | -$216K | 0.03% | 452 |
|
|
2018
Q1 | $1.43M | Sell |
4,150
-3,502
| -46% | -$1.22M | 0.04% | 406 |
|
|
2017
Q4 | $2.88M | Buy |
7,652
+218
| +3% | +$88.3K | 0.08% | 281 |
|
|
2017
Q3 | $3.32M | Sell |
7,434
-2,040
| -22% | -$971K | 0.1% | 240 |
|
|
2017
Q2 | $4.65M | Buy |
9,474
+429
| +5% | +$188K | 0.15% | 159 |
|
|
2017
Q1 | $3.5M | Sell |
9,045
-659
| -7% | -$244K | 0.11% | 211 |
|
|
2016
Q4 | $3.56M | Buy |
9,704
+321
| +3% | +$122K | 0.12% | 203 |
|
|
2016
Q3 | $3.77M | Buy |
9,383
+693
| +8% | +$278K | 0.12% | 189 |
|
|
2016
Q2 | $3.03M | Buy |
8,690
+114
| +1% | +$43.9K | 0.11% | 212 |
|
|
2016
Q1 | $3.09M | Buy |
8,576
+744
| +9% | +$307K | 0.11% | 212 |
|
|
2015
Q4 | $4.25M | Sell |
7,832
-202
| -3% | -$109K | 0.15% | 166 |
|
|
2015
Q3 | $3.74M | Sell |
8,034
-933
| -10% | -$501K | 0.14% | 180 |
|
|
2015
Q2 | $4.58M | Sell |
8,967
-1,216
| -12% | -$593K | 0.16% | 154 |
|
|
2015
Q1 | $4.6M | Sell |
10,183
-2
| -0% | -$848 | 0.15% | 154 |
|
|
2014
Q4 | $4.18M | Sell |
10,185
-2,066
| -17% | -$812K | 0.14% | 161 |
|
|
2014
Q3 | $4.42M | Sell |
12,251
-413
| -3% | -$138K | 0.15% | 157 |
|
|
2014
Q2 | $3.58M | Sell |
12,664
-912
| -7% | -$270K | 0.11% | 194 |
|
|
2014
Q1 | $4.08M | Buy |
13,576
+517
| +4% | +$159K | 0.14% | 166 |
|
|
2013
Q4 | $3.6M | Sell |
13,059
-2,931
| -18% | -$843K | 0.12% | 188 |
|
|
2013
Q3 | $5M | Sell |
15,990
-3,147
| -16% | -$828K | 0.18% | 123 |
|
|
2013
Q2 | $4.3M | Buy |
+19,137
| New | +$4.46M | 0.16% | 132 |
|
Other funds holding REGN
BOK Financial's REGN Position: Q2 2026 in Review
BOK Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 0.37% in Q2 2026, selling an estimated $3.4K and leaving 1,346 shares worth $839K. The position accounts for 0.01% of the portfolio, ranked #460.
BOK Financial first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $5M in Q3 2013. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- BOK Financial held 1,346 shares of Regeneron Pharmaceuticals worth $839K as of Q2 2026.
- BOK Financial sold 5 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.4K.
- Regeneron Pharmaceuticals made up 0.01% of BOK Financial's portfolio in Q2 2026, its #460 holding.
- BOK Financial first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- BOK Financial's Regeneron Pharmaceuticals position peaked at $5M in Q3 2013.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.